Trachoma: Leading cause of infectious blindness

CMAJ. Canadian Medical Association Journal

Volumn 170, Issue 8, 2004, Pages 1225-

  Weir, Erica ^c   Haider, Shariq ^a   Telio, David ^b  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; TETRACYCLINE;

BLINDNESS; CHLAMYDIA TRACHOMATIS; HUMAN; IMMUNOFLUORESCENCE; KERATOCONJUNCTIVITIS; RECURRENT DISEASE; SEROTYPE; SHORT SURVEY; TRACHOMA; TRICHIASIS; WORLD HEALTH ORGANIZATION;

EID: 2142755920     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040286     Document Type: Short Survey

References (4)

1. Mabey DC, Solomon AW, Foster A. Trachoma. Lancet 2003;362:223-9.
2. Global elimination of blinding trachoma [WHO EB101.R5]. Geneva: World Health Organization; 1998. Available: www.who.int/pbd/trachoma/ebres98-e.htm (accessed 2004 Mar 16).
3. Mecaskey JW, Knirsch CA, Kumaresan JA, Cook JA. The possibility of eliminating blinding trachoma. Lancet Infect Dis 2003;3(11):728-34.
4. Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis 2003;3(6):372-81.